The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

Scot Garg; Patrick W Serruys; Sigmund Silber; Joanna Wykrzykowska; Robert Jan van Geuns; Gert Richardt; Pawel E Buszman; Henning Kelbæk; Adrianus Johannes van Boven; Sjoerd H Hofma; Axel Linke; Volker Klauss; William Wijns; Carlos Macaya; Philippe Garot; Carlo DiMario; Ganesh Manoharan; Ran Kornowski; Thomas Ischinger; Antonio Bartorelli; Eric Van Remortel; Jacintha Ronden; Stephan Windecker

doi:10.1016/j.jcin.2011.01.008

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

Scot Garg, Patrick W Serruys, Sigmund Silber, Joanna Wykrzykowska, Robert Jan van Geuns, Gert Richardt, Pawel E Buszman, Henning Kelbæk, Adrianus Johannes van Boven, Sjoerd H Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo DiMario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio BartorelliEric Van Remortel, Jacintha Ronden, Stephan Windecker

100 Citationer (Scopus)

Abstract

This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.

Originalsprog	Engelsk
Tidsskrift	JACC. Cardiovascular interventions
Vol/bind	4
Udgave nummer	4
Sider (fra-til)	432-41
Antal sider	10
DOI	https://doi.org/10.1016/j.jcin.2011.01.008
Status	Udgivet - 2011

Adgang til dokumentet

10.1016/j.jcin.2011.01.008

Citationsformater

Garg, S., Serruys, P. W., Silber, S., Wykrzykowska, J., van Geuns, R. J., Richardt, G., Buszman, P. E., Kelbæk, H., van Boven, A. J., Hofma, S. H., Linke, A., Klauss, V., Wijns, W., Macaya, C., Garot, P., DiMario, C., Manoharan, G., Kornowski, R., Ischinger, T., ... Windecker, S. (2011). The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC. Cardiovascular interventions, 4(4), 432-41. https://doi.org/10.1016/j.jcin.2011.01.008

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. / Garg, Scot; Serruys, Patrick W; Silber, Sigmund et al.
I: JACC. Cardiovascular interventions, Bind 4, Nr. 4, 2011, s. 432-41.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Garg, S, Serruys, PW, Silber, S, Wykrzykowska, J, van Geuns, RJ, Richardt, G, Buszman, PE, Kelbæk, H, van Boven, AJ, Hofma, SH, Linke, A, Klauss, V, Wijns, W, Macaya, C, Garot, P, DiMario, C, Manoharan, G, Kornowski, R, Ischinger, T, Bartorelli, A, Van Remortel, E, Ronden, J & Windecker, S 2011, 'The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial', JACC. Cardiovascular interventions, bind 4, nr. 4, s. 432-41. https://doi.org/10.1016/j.jcin.2011.01.008

@article{4a419434fb4b4419a5ff8aa1b91432ca,

title = "The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial",

abstract = "This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.",

keywords = "Aged, Angioplasty, Balloon, Coronary, Cardiovascular Agents, Coronary Artery Disease, Coronary Restenosis, Drug-Eluting Stents, Europe, Female, Health Status Indicators, Humans, Israel, Kaplan-Meier Estimate, Linear Models, Male, Middle Aged, Myocardial Infarction, Predictive Value of Tests, Proportional Hazards Models, Prospective Studies, Prosthesis Design, Risk Assessment, Risk Factors, Sirolimus, Survival Rate, Time Factors, Treatment Outcome",

author = "Scot Garg and Serruys, {Patrick W} and Sigmund Silber and Joanna Wykrzykowska and {van Geuns}, {Robert Jan} and Gert Richardt and Buszman, {Pawel E} and Henning Kelb{\ae}k and {van Boven}, {Adrianus Johannes} and Hofma, {Sjoerd H} and Axel Linke and Volker Klauss and William Wijns and Carlos Macaya and Philippe Garot and Carlo DiMario and Ganesh Manoharan and Ran Kornowski and Thomas Ischinger and Antonio Bartorelli and {Van Remortel}, Eric and Jacintha Ronden and Stephan Windecker",

year = "2011",

doi = "10.1016/j.jcin.2011.01.008",

language = "English",

volume = "4",

pages = "432--41",

journal = "JACC. Cardiovascular interventions",

issn = "1941-7632",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

AU - Garg, Scot

AU - Serruys, Patrick W

AU - Silber, Sigmund

AU - Wykrzykowska, Joanna

AU - van Geuns, Robert Jan

AU - Richardt, Gert

AU - Buszman, Pawel E

AU - Kelbæk, Henning

AU - van Boven, Adrianus Johannes

AU - Hofma, Sjoerd H

AU - Linke, Axel

AU - Klauss, Volker

AU - Wijns, William

AU - Macaya, Carlos

AU - Garot, Philippe

AU - DiMario, Carlo

AU - Manoharan, Ganesh

AU - Kornowski, Ran

AU - Ischinger, Thomas

AU - Bartorelli, Antonio

AU - Van Remortel, Eric

AU - Ronden, Jacintha

AU - Windecker, Stephan

PY - 2011

Y1 - 2011

N2 - This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.

AB - This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.

KW - Aged

KW - Angioplasty, Balloon, Coronary

KW - Cardiovascular Agents

KW - Coronary Artery Disease

KW - Coronary Restenosis

KW - Drug-Eluting Stents

KW - Europe

KW - Female

KW - Health Status Indicators

KW - Humans

KW - Israel

KW - Kaplan-Meier Estimate

KW - Linear Models

KW - Male

KW - Middle Aged

KW - Myocardial Infarction

KW - Predictive Value of Tests

KW - Proportional Hazards Models

KW - Prospective Studies

KW - Prosthesis Design

KW - Risk Assessment

KW - Risk Factors

KW - Sirolimus

KW - Survival Rate

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1016/j.jcin.2011.01.008

DO - 10.1016/j.jcin.2011.01.008

M3 - Journal article

C2 - 21511223

SN - 1941-7632

VL - 4

SP - 432

EP - 441

JO - JACC. Cardiovascular interventions

JF - JACC. Cardiovascular interventions

IS - 4

ER -

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater